High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus

San-Juan, Rafael; Viedma, Esther; Chaves, Fernando; Lalueza, Antonio; Fortún, Jesús; Loza, Elena; Pujol, Miquel; Ardanuy, Carmen; Morales, Isabel; de Cueto, Marina; Resino-Foz, Elena; Morales-Cartagena, Alejandra; Rico, Alicia; Romero, María P.; Orellana, María Ángeles; López-Medrano, Francisco; Fernández-Ruiz, Mario; Aguado, José María

doi:10.3201/eid2206.151709

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

High MICs for Vancomycin and Daptomycin and Complicated Catheter-Related Bloodstream Infections with Methicillin-Sensitive Staphylococcus aureus

Published Date:

Jun 2016

Publisher's site:

http://dx.doi.org/10.3201/eid2206.151709 New Site Icon

Source:

Emerg Infect Dis. 22(6):1057-1066.

[PDF-1.52 MB]

Details:

Personal Authors:

San-Juan, Rafael ; Viedma, Esther ; Chaves, Fernando ; Lalueza, Antonio ; Fortún, Jesús ; ... More ▼

Keywords:

[+]

Pubmed ID:

27192097

Pubmed Central ID:

PMC4880091

Description:

We investigated the prognostic role of high MICs for antistaphylococcal agents in patients with methicillin-sensitive Staphylococcus aureus catheter-related bloodstream infection (MSSA CRBSI). We prospectively reviewed 83 episodes from 5 centers in Spain during April 2011-June 2014 that had optimized clinical management and analyzed the relationship between E-test MICs for vancomycin, daptomycin, oxacillin, and linezolid and development of complicated bacteremia by using multivariate analysis. Complicated MSSA CRBSI occurred in 26 (31.3%) patients; MICs for vancomycin and daptomycin were higher in these patients (optimal cutoff values for predictive accuracy = 1.5 μg/mL and 0.5 μg/mL). High MICs for vancomycin (hazard ratio 2.4, 95% CI 1.2-5.5) and daptomycin (hazard ratio 2.4, 95% CI 1.1-5.9) were independent risk factors for development of complicated MSSA CRBSI. Our data suggest that patients with MSSA CRBSI caused by strains that have high MICs for vancomycin or daptomycin are at increased risk for complications.

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

Supporting Files:

	15-1709-F.gif	image/gif
	15-1709-F.jpg	image/jpeg
	15-1709-Techapp-s1.pdf	application/pdf
	15-1709.nxml	application/octet-stream
	license.txt	text/plain

No Related Documents.

You May Also Like:

High Vancomycin MIC and Complicated Methicillin-Susceptible Staphylococcus aureus Bacteremia

Personal Author:

Aguado, Jose Maria; San-Juan, Rafael; Lalueza, Antonio; Sanz, Francisca; Rodríguez-Otero, Joaquin; Gómez-Gonzalez, Carmen; Chaves, Fernando;

Published:

Jun 2011

Source:

Emerg Infect Dis. 17(6):1099-1102.

Description:

We conducted a retrospective study of 99 patients with methicillin-suseptible Staphylococcus aureus catheter-related bacteremia in which vancomycin MIC was determined by Etest. High vancomycin MIC (>1.5 ug/mL) was the only independent risk factor for...

File Type:

[PDF - 212.17 KB]
De Novo Daptomycin-Nonsusceptible Enterococcal Infections

Personal Author:

Kelesidis, Theodoros; Humphries, Romney; Uslan, Daniel Z.; Pegues, David;

Published:

Apr 2012

Source:

Emerg Infect Dis. 18(4):674-676.

Description:

Potential emergence of enterococcal daptomycin nonsusceptibility among patients with no prior exposure to daptomycin poses clinical and public health challenges. We found that development of infections with daptomycin-nonsusceptible enterococci in th...

File Type:

[PDF - 165.20 KB]
Daptomycin vs. vancomycin for osteoarticular infections due to methicillin-resistant Staphylococcus aureus (MRSA): A nested case-control study

Personal Author:

Liang, Stephen Y.; Khair, Hani N.; McDonald, Jay R.; Babcock, Hilary M.; Marschall, Jonas;

Published:

Nov 03 2013

Source:

Eur J Clin Microbiol Infect Dis. 33(4):659-664.

Description:

Purpose : Vancomycin is the standard antibiotic for treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections. While daptomycin is approved for MRSA bacteremia, its effectiveness in osteoarticular infections (OAI) has not been establ...

File Type:

[PDF - 117.29 KB]
Intermediate Vancomycin Susceptibility in a Community-associated MRSA Clone

Personal Author:

Graber, Christopher J.; Wong, Margaret K.; Carleton, Heather A.; Perdreau-Remington, Françoise; Haller, Barbara L.; Chambers, Henry F.;

Published:

Mar 2007

Source:

Emerg Infect Dis. 13(3):491-493.

Description:

We describe a case of treatment failure caused by a strain of USA300 community-associated methicillin-resistant Staphylococcus aureus (MRSA) with intermediate susceptibility to vancomycin and reduced susceptibility to daptomycin. The strain was isola...

File Type:

[PDF - 66.94 KB]
Predicting Risk for Death from MRSA Bacteremia1

Personal Author:

Pastagia, Mina; Kleinman, Lawrence C.; Lacerda de la Cruz, Eliesel G.; Jenkins, Stephen G.;

Published:

Jul 2012

Source:

Emerg Infect Dis. 18(7):1072-1080.

Description:

Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia is often fatal. To determine predictors of risk for death, we conducted a retrospective cohort study. We examined 699 episodes of MRSA bacteremia involving 603 patients admitted to an acad...

File Type:

[PDF - 271.68 KB]